Related Topic: Radioisotopes

Design work for Argentina's radioisotope production plant under way

Design work for Argentina's radioisotope production plant under way

Argentina's National Atomic Energy Commission and nuclear construction specialists INVAP have held a workshop focused on the design of the facility which will form part of the complex alongside the new RA-10 multipurpose reactor.

New Nuclear 23 April 2024


Podcast: How nuclear 'waste' can save lives (and power spacecraft)

Podcast: How nuclear 'waste' can save lives (and power spacecraft)

Professor Tim Tinsley outlines how material extracted from the UK's legacy nuclear material is being used in pioneering cancer treatments and for powering future space missions - and considers whether long-term disposal plans now need to take into account the current and potential future value in the material.

Other News 01 April 2024


Most Read


China starts mass production of carbon-14 isotope

China starts mass production of carbon-14 isotope

The carbon-14 isotope is being produced at the Qinshan nuclear power plant, China National Nuclear Corporation has announced.

New Nuclear 22 April 2024


Framatome, KHNP to cooperate on medical isotope production

Framatome, KHNP to cooperate on medical isotope production

Framatome and Korea Hydro & Nuclear Power are to assess the feasibility of producing medical isotope lutetium-177 in the Candu pressurised heavy water reactors at the Wolsong nuclear power plant in South Korea.

Corporate 18 April 2024


Agreements with Burkina Faso, Nicaragua and Kazakhstan at Atomexpo

Agreements with Burkina Faso, Nicaragua and Kazakhstan at Atomexpo

Russia's Rosatom has signed agreements relating to developing nuclear medicine centres in Nicaragua and Kazakhstan, and also a memorandum of understanding with Burkina Faso which includes potential nuclear energy projects.

Nuclear Policies 26 March 2024


Construction starts on French lead-212 production facility

Construction starts on French lead-212 production facility

Orano subsidiary Orano Med has laid the foundation stone for its Alpha Therapy Laboratory in Onnaing in northern France. This will be Europe's first industrial-scale pharmaceutical facility dedicated to the production of lead-212 based radioligand therapies.

Regulation & Safety 06 February 2024


New partnerships further radioisotope power plans

New partnerships further radioisotope power plans

Zeno Power's first full-scale radioisotope power systems will be fuelled by strontium-90 material recycled from a legacy radioisotope generator under a new public-private partnership with the US Department of Energy Oak Ridge Office of Environmental Management. The company has also announced a partnership with Westinghouse to fabricate the heat sources for its systems.

New Nuclear 30 January 2024


Nuclear battery: Chinese firm aiming for mass market production

Nuclear battery: Chinese firm aiming for mass market production

Beijing Betavolt New Energy Technology Company Ltd claims to have developed a miniature atomic energy battery that can generate electricity stably and autonomously for 50 years without the need for charging or maintenance. It said the battery is currently in the pilot stage and will be put into mass production on the market.

Corporate 16 January 2024


Nuclearelectrica gets EIB funding for tritium removal facility

Nuclearelectrica gets EIB funding for tritium removal facility

Romania's Nuclearelectrica has secured a loan agreement of EUR145 million (USD159 million) with the European Investment Bank towards the completion of what will be Europe's first Tritium Removal Facility, at the Cernavoda nuclear power plant.

New Nuclear 05 January 2024


Canadian collaboration to explore isotope production for space exploration

Canadian collaboration to explore isotope production for space exploration

The Canadian Nuclear Isotope Council and nuclear innovation company Nuclear Promise X will explore the feasibility of using Canadian nuclear reactors to produce plutonium-238 for use in deep space exploration.

Corporate 05 January 2024